Benefits of a combined surgical technique for patients with secondary neovascular glaucoma
Author:
Affiliation:
1. BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE
2. SHUPYK NATIONAL HEALTHCARE UNIVERSITY OF UKRAINE, KYIV, UKRAINE
3. NATIONAL TECHNICAL UNIVERSITY OF UKRAINE ≪IGOR SIKORSKY KYIV POLYTECHNIC INSTITUTE≫, KYIV, UKRAINE
Abstract
Publisher
ALUNA
Reference15 articles.
1. 1. Mogilevskiy SYu, Korobova AV, Hadri W. Svyaz’ provospalitel’nykh tsitokinov vnutriglaznoy zhidkosti s razvitiyem posleoperatsionnykh oslozhneniy u bol’nykh pervichnoy glaukomoy v sochetanii s kataraktoy [Association of pro-inflammatory cytokines in the intraocular fluid with the development of postoperative complications in patients with primary glaucoma in combination with cataracts]. Archive of Ukrainian Ophthalmology. 2017;2(8):38–44. doi: 10.22141/2309-8147.5.2.2017.172452. (Ukrainian)
2. 2. Pavlyuchenko KP, Mogilevskiy SYu, Zyablitsev SV et al. Dinamika razvitiya neovaskulyarizatsii raduzhki v zavisimosti ot urovnya vazomotornykh faktorov u bol’nykh neovaskulyarnoy glaukomoy [Dynamics of development of iris neovascularization depending on the level of vasomotor factors in patients with neovascular glaucoma]. Archive of Ukrainian Ophthalmology. 2013;1(1):55–59. doi: 10.22141/2309-8147.1.1.2013.173772. (Ukrainian)
3. 3. Li YJ, Hu D, Lv PL et al. Expression of platelet-derived growth factor-C in aqueous humor of patients with neovascular glaucoma and its correlation with vascular endothelial growth factor. Eur J Ophthalmol. 2020;30(3):500–505. doi: 10.1177/1120672119832785.
4. 4. Sun Y, Liang Y, Zhou P et al. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term. BMC Ophthalmol. 2016;16(1):1-8. doi: 10.1186/s12886-016-0327-9.
5. 5. Junki K, Kyung R. Effect of Preoperative Intravitreal Bevacizumab on the Surgical. Outcome of Neovascular Glaucoma at Different Stages. J. Ophthalm. 2017;1:1-7. doi: 10.1155/2017/7672485.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3